Combination vaccines: postlicensure safety evaluation

Area of Science:

• Public Health
• Immunology
• Pharmacovigilance

Background:

• Vaccine-preventable diseases have significantly decreased due to successful immunization programs.
• Limitations in prelicensure vaccine safety trials necessitate robust postlicensure safety surveillance.
• Public trust in vaccines requires ongoing assessment of potential risks, including those from combination vaccines.

Purpose of the Study:

• To review and recommend measures for enhancing postlicensure vaccine safety monitoring.
• To address the growing need for studying vaccine risks in the context of widespread immunization.
• To ensure public confidence in vaccine safety through improved infrastructure and methodologies.

Main Methods:

• Establishment of clinical immunization safety assessment centers.
• Standardization of case definitions for adverse events following immunization (AEFI).
• Utilization of the Vaccine Identification Standards Initiative (VISI) for improved data transfer.
• Integration of vaccine safety monitoring within immunization registries.
• Expansion of the Vaccine Safety Datalink (VSD) project.
• Application of innovative analytical tools for enhanced signal detection.
• Implementation of methods to mitigate confounding by contraindication.

Main Results:

• The article outlines a comprehensive set of strategies to strengthen vaccine safety infrastructure.
• These measures aim to improve the accuracy, efficiency, and scope of postlicensure vaccine safety studies.
• The proposed infrastructure enhancements are designed to build public confidence in immunization.

Conclusions:

• Significant investment in vaccine safety infrastructure, comparable to vaccine development, is essential.
• Enhanced postlicensure surveillance and data analysis are critical for maintaining public trust in vaccines.
• A proactive approach to vaccine safety is necessary to sustain high immunization rates and public confidence.